Guest Host: Rebecca Roberts

The genetic material in our cells make us who we are. But since 1982, the U.S. Patent and Trade Office has issued tens of thousands of patents to private companies for gene-related products. The biotechnology industry says these patents are necessary to spur innovation. Opponents say they actually stifle science. We examine the intersection of cutting-edge genetic research and intellectual property.


  • Joshua D. Sarnoff Professor of the Practice of Law, American University's Washington College of Law
  • Hans Sauer Associate General Counsel for Intellectual Property, Biotechnology Industry Organization
  • Shobita Parthasarathy Co-Director, Science, Technology and Public Policy Program, Ford School of Public Policy, University of Michigan; author, "Building Genetic Medicine: Breast Cancer, Technology, and the Comparative Politics of Health Care" (MIT Press)

Topics + Tags


comments powered by Disqus
Most Recent Shows

The Politics Hour – October 20, 2017

Friday, Oct 20 2017Montgomery County State's Attorney John McCarthy discusses his efforts to address gang violence. Plus, D.C. Councilmember Trayon White joins us to recap the "grocery march" protesting food deserts east of the Anacostia River.